Immune checkpoint inhibitors related respiratory disorders in patients with lung cancer: A meta-analysis of randomized controlled trials

BACKGROUND: In recent years, immune checkpoint inhibitors (ICIs) had extremely rapid growth in anti-cancer and improved outcomes of many malignancies, specifically lung cancer. However, the incidence of ICIs-related adverse events also raised. Using this meta-analysis, ICIs-related respiratory disor...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Han, Luo, Sean X., Jie, Jing, Peng, Liping, Wang, Shuai, Song, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011157/
https://www.ncbi.nlm.nih.gov/pubmed/36926326
http://dx.doi.org/10.3389/fimmu.2023.1115305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011157/
https://www.ncbi.nlm.nih.gov/pubmed/36926326
http://dx.doi.org/10.3389/fimmu.2023.1115305

Ejemplares similares